Reports reveal that the CIA collaborated with the National Institute of Allergy and Infectious Diseases (NIAID), formerly directed by Anthony Fauci, to advance biodefense research. This partnership reportedly allowed the CIA to access sensitive germ research under the guise of civilian efforts.
The CIA used funds to leverage existing civilian research to benefit both the CIA and NIAID.
An undated agreement indicated the establishment of the CIA’s Biological Technology Center, focused on bioterrorism research.
The collaboration involved studying "forensic microbiology" related to bioterrorism agents for intelligence purposes.
Research was classified as sensitive but not officially classified, with the CIA controlling access to information.
The CIA aimed to enhance its existing capabilities in detecting and identifying viruses, thereby offering support to NIAID in obtaining necessary germs.
The Biological Technology Center also partnered with the Intelligence Technology Innovation Center and a private nonprofit located near NIH headquarters.
This partnership illustrates a blending of government intelligence and civilian research efforts, aimed at improving national security against biochemical threats. The details of this collaboration reflect ongoing efforts to enhance biodefense mechanisms through strategic governmental partnerships.
No comments:
Post a Comment